INSTITUTION'S PROFILE
University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe
Publications (4)
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial.
Journal: The lancet. HIV
Publication date:
Journal: The lancet. HIV
Publication Year:
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex.
Journal: AIDS care
Publication date: 2024
Journal: AIDS care
Publication Year: 2024
IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation.
Journal: Frontiers in reproductive health
Publication date:
Journal: Frontiers in reproductive health
Publication Year:
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial.
Journal: EClinicalMedicine
Publication date:
Journal: EClinicalMedicine
Publication Year: